Fibroblast growth factor-23 but not sKlotho levels are related to diastolic dysfunction in type 1 diabetic patients with early diabetic nephropathy

DOĞAN, BURCU; ARIKAN, İZZET; Guler, Derya; Keles, Nursen; Isbilen, Banu; Isman, Ferruh; OĞUZ, AYTEKİN

doi:10.1007/s11255-015-1190-y

Fibroblast growth factor-23 but not sKlotho levels are related to diastolic dysfunction in type 1 diabetic patients with early diabetic nephropathy

Atıf İçin Kopyala

DOĞAN B., ARIKAN İ. H., Guler D., Keles N., Isbilen B., Isman F., ...Daha Fazla

INTERNATIONAL UROLOGY AND NEPHROLOGY, cilt.48, sa.3, ss.399-407, 2016 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 48 Sayı: 3
Basım Tarihi: 2016
Doi Numarası: 10.1007/s11255-015-1190-y
Dergi Adı: INTERNATIONAL UROLOGY AND NEPHROLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.399-407
Anahtar Kelimeler: Type 1 diabetes mellitus, sKlotho, FGF-23, Cardiac function, Diabetic nephropathy, CHRONIC KIDNEY-DISEASE, LEFT-VENTRICULAR HYPERTROPHY, SOLUBLE SERUM KLOTHO, HEART-FAILURE, CARDIOVASCULAR-DISEASE, VASCULAR DYSFUNCTION, FGF-23, MORTALITY, PHOSPHATE, COMMUNITY
Marmara Üniversitesi Adresli: Evet

Özet

To investigate the soluble Klotho (sKlotho) and fibroblast growth factor-23 (FGF-23) levels and echocardiographic findings in type 1 diabetic patients with no or early diabetic nephropathy.